Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Peritoneal Dialysis Access Management: More Than Skin Deep.

Bridger S.

Nephrol Nurs J. 2017 Sep-Oct;44(5):401-446.

PMID:
29160975
2.

Adjusting to the caregiving role: the importance of coping and support.

Epiphaniou E, Hamilton D, Bridger S, Robinson V, Rob G, Beynon T, Higginson I, Harding R.

Int J Palliat Nurs. 2012 Nov;18(11):541-5.

PMID:
23413502
3.

Genome sequencing of a genetically tractable Pyrococcus furiosus strain reveals a highly dynamic genome.

Bridger SL, Lancaster WA, Poole FL 2nd, Schut GJ, Adams MW.

J Bacteriol. 2012 Aug;194(15):4097-106. doi: 10.1128/JB.00439-12. Epub 2012 May 25.

4.

What are the perceived needs and challenges of informal caregivers in home cancer palliative care? Qualitative data to construct a feasible psycho-educational intervention.

Harding R, Epiphaniou E, Hamilton D, Bridger S, Robinson V, George R, Beynon T, Higginson IJ.

Support Care Cancer. 2012 Sep;20(9):1975-82. doi: 10.1007/s00520-011-1300-z. Epub 2011 Nov 10.

PMID:
22072049
5.

Deletion strains reveal metabolic roles for key elemental sulfur-responsive proteins in Pyrococcus furiosus.

Bridger SL, Clarkson SM, Stirrett K, DeBarry MB, Lipscomb GL, Schut GJ, Westpheling J, Scott RA, Adams MW.

J Bacteriol. 2011 Dec;193(23):6498-504. doi: 10.1128/JB.05445-11. Epub 2011 Sep 30.

7.

Transcriptional and biochemical analysis of starch metabolism in the hyperthermophilic archaeon Pyrococcus furiosus.

Lee HS, Shockley KR, Schut GJ, Conners SB, Montero CI, Johnson MR, Chou CJ, Bridger SL, Wigner N, Brehm SD, Jenney FE Jr, Comfort DA, Kelly RM, Adams MW.

J Bacteriol. 2006 Mar;188(6):2115-25.

8.

Population density-dependent regulation of exopolysaccharide formation in the hyperthermophilic bacterium Thermotoga maritima.

Johnson MR, Montero CI, Conners SB, Shockley KR, Bridger SL, Kelly RM.

Mol Microbiol. 2005 Feb;55(3):664-74.

10.

Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p.

Hampe J, Frenzel H, Mirza MM, Croucher PJ, Cuthbert A, Mascheretti S, Huse K, Platzer M, Bridger S, Meyer B, Nürnberg P, Stokkers P, Krawczak M, Mathew CG, Curran M, Schreiber S.

Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):321-6. Epub 2001 Dec 18.

11.

Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.

Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJ, Bridger S, van Deventer S, Forbes A, Nikolaus S, Lennard-Jones JE, Foelsch UR, Krawczak M, Lewis C, Schreiber S, Mathew CG.

Lancet. 2001 Jun 16;357(9272):1925-8. Erratum in: Lancet 2002 Sep 7;360(9335):806.

PMID:
11425413
12.

Impaired pancreatic secretion in severely malnourished patients is a consequence of primary pancreatic dysfunction.

Winter TA, Marks T, Callanan M, O'Keefe SJ, Bridger S.

Nutrition. 2001 Mar;17(3):230-5.

PMID:
11312065
13.

Correlation between the immune responses to collagens type I, III, IV and V and Klebsiella pneumoniae in patients with Crohn's disease and ankylosing spondylitis.

Tiwana H, Natt RS, Benitez-Brito R, Shah S, Wilson C, Bridger S, Harbord M, Sarner M, Ebringer A.

Rheumatology (Oxford). 2001 Jan;40(1):15-23.

PMID:
11157137
14.

Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel disease.

Hampe J, Lynch NJ, Daniels S, Bridger S, Macpherson AJ, Stokkers P, Forbes A, Lennard-Jones JE, Mathew CG, Curran ME, Schreiber S.

Gut. 2001 Feb;48(2):191-7.

15.

A simple method for assessing intestinal inflammation in Crohn's disease.

Tibble J, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridger S, Foster R, Sherwood R, Fagerhol M, Bjarnason I.

Gut. 2000 Oct;47(4):506-13.

16.

Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease.

Tibble JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I.

Gastroenterology. 2000 Jul;119(1):15-22.

PMID:
10889150
17.

Analysis of single-nucleotide polymorphisms in the interleukin-4 receptor gene for association with inflammatory bowel disease.

Olavesen MG, Hampe J, Mirza MM, Saiz R, Lewis CM, Bridger S, Teare D, Easton DF, Herrmann T, Scott G, Hirst J, Sanderson J, Hodgson SV, Lee J, MacPherson A, Schreiber S, Lennard-Jones JE, Curran ME, Mathew CG.

Immunogenetics. 2000 Jan;51(1):1-7.

PMID:
10663555
18.

Linkage of inflammatory bowel disease to human chromosome 6p.

Hampe J, Shaw SH, Saiz R, Leysens N, Lantermann A, Mascheretti S, Lynch NJ, MacPherson AJ, Bridger S, van Deventer S, Stokkers P, Morin P, Mirza MM, Forbes A, Lennard-Jones JE, Mathew CG, Curran ME, Schreiber S.

Am J Hum Genet. 1999 Dec;65(6):1647-55.

19.

Why children with inflammatory bowel disease are diagnosed at a younger age than their affected parent.

Lee JC, Bridger S, McGregor C, Macpherson AJ, Jones JE.

Gut. 1999 Jun;44(6):808-11.

20.

A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort.

Hampe J, Schreiber S, Shaw SH, Lau KF, Bridger S, Macpherson AJ, Cardon LR, Sakul H, Harris TJ, Buckler A, Hall J, Stokkers P, van Deventer SJ, Nürnberg P, Mirza MM, Lee JC, Lennard-Jones JE, Mathew CG, Curran ME.

Am J Hum Genet. 1999 Mar;64(3):808-16.

21.

Well-defined outcomes documentation needed.

Lewis NM, Bridger S.

J Am Diet Assoc. 1999 Jan;99(1):16-7. No abstract available.

PMID:
9917724
22.

The interferon-gamma gene as a positional and functional candidate gene for inflammatory bowel disease.

Hampe J, Hermann B, Bridger S, MacPherson AJ, Mathew CG, Schreiber S.

Int J Colorectal Dis. 1998;13(5-6):260-3.

PMID:
9870173
23.

Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16.

Curran ME, Lau KF, Hampe J, Schreiber S, Bridger S, Macpherson AJ, Cardon LR, Sakul H, Harris TJ, Stokkers P, Van Deventer SJ, Mirza M, Raedler A, Kruis W, Meckler U, Theuer D, Herrmann T, Gionchetti P, Lee J, Mathew C, Lennard-Jones J.

Gastroenterology. 1998 Nov;115(5):1066-71.

PMID:
9797359
24.

Basal and pentagastrin stimulated acid secretion in duodenal ulcer subjects before and after Helicobacter pylori eradication: a 12-month follow-up study.

Louw JA, Young GO, Lucke W, Bridger S, Winter TA, Marks IN.

Ital J Gastroenterol Hepatol. 1998 Aug;30(4):363-7.

PMID:
9789128
25.

Deaths from low dose paracetamol poisoning.

Bridger S, Henderson K, Glucksman E, Ellis AJ, Henry JA, Williams R.

BMJ. 1998 Jun 6;316(7146):1724-5. Review. No abstract available.

26.

Multiple cerebral venous thromboses in a child with inflammatory bowel disease.

Bridger S, Evans N, Parker A, Cairns SR.

J Pediatr Gastroenterol Nutr. 1997 Nov;25(5):533-6. No abstract available.

PMID:
9360209
27.

Warfarin use in patients with atrial fibrillation. Better surveillance is needed.

Bridger S.

BMJ. 1997 Sep 20;315(7110):750-1. No abstract available.

28.
29.

Biodistribution of model 105Rh-labeled tetradentate thiamacrocycles in rats.

Li N, Struttman M, Higginbotham C, Grall AJ, Skerlj JF, Vollano JF, Bridger SA, Ochrymowycz LA, Ketring AR, Abrams MJ, Volkert WA.

Nucl Med Biol. 1997 Jan;24(1):85-92.

PMID:
9080479
30.
31.

Changes in nocturnal and peak acid outputs after duodenal ulcer healing with sucralfate or ranitidine.

Kummer AF, Johnston DA, Marks IN, Young GO, Tigler-Wybrandi NA, Bridger SA.

Gut. 1992 Feb;33(2):175-8.

32.

Basal and maximum acid output after continuous overnight gastric aspiration.

Johnston DA, Kummer AF, Young GO, Tigler-Wybrandi NA, Bridger S, Marks IN.

Am J Gastroenterol. 1991 Sep;86(9):1147-9.

PMID:
1882792
33.

Acid secretory responses and parietal cell sensitivity following duodenal ulcer healing with omeprazole, sucralfate, and Maalox.

Johnston DA, Marks IN, Young GO, Tigler-Wybrandi NA, Bridger S, Zak J.

Am J Med. 1991 Aug 8;91(2A):91S-94S.

PMID:
1882910
34.

Duodenal ulcer healing and acid secretory responses to modified sham feeding and pentagastrin stimulation.

Johnston DA, Marks IN, Young GO, Tigler-Wybrandi NA, Bridger S.

Aliment Pharmacol Ther. 1990 Aug;4(4):403-10.

PMID:
2103758
35.

Acid-secretory response and parietal cell sensitivity in patients with duodenal ulcer before and after treatment with sucralfate or ranitidine.

Marks IN, Young GO, Tigler-Wybrandi NA, Bridger S, Newton KA.

Am J Med. 1989 Jun 9;86(6A):145-7.

PMID:
2735330
36.

Does gastric acid secretion affect phosphate binding by aluminium phosphate binding gels in chronic renal failure?

Cassidy M, Swanepoel C, Bridger S, Marks IN.

Nephrol Dial Transplant. 1988;3(3):358. No abstract available.

PMID:
3140119
37.

Congenital contractural deformities of the fingers and arthropathy.

Martin JR, Huang SN, Lacson A, Payne RH, Bridger S, Fraser FC, Neary AJ, MacLaughlin EA, Hobeika C, Lawton LJ.

Ann Rheum Dis. 1985 Dec;44(12):826-30.

38.

Causes and prevalence of blindness in the Northern Province of Sierra Leone.

Stilma JS, Bridger S.

Doc Ophthalmol. 1983 Dec 15;56(1-2):115-22.

PMID:
6661998
39.

The effects of stimulus complexity and sensory modality on reaction time in normal and retarded readers.

Blank M, Berenzweig SS, Bridger SH.

Child Dev. 1975 Mar;46(1):133-40.

PMID:
1132266

Supplemental Content

Loading ...
Support Center